Prevention of Renal and Vascular Endstage Disease Intervention Trial
Conditions:   Microalbuminuria;   Cardiovascular Diseases;   Renal Disease Interventions:   Drug: Fosinopril;   Drug: Pravastatin;   Drug: Fosinopril Placebo;   Drug: Pravastatin Placebo Sponsors:   University Medical Center Groningen;   Dutch Kidney Foundation;   Netherlands Heart Foundation Completed - verified March 2017 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 27, 2017 Category: Research Source Type: clinical trials

Prevention of Renal and Vascular Endstage Disease Intervention Trial
Conditions:   Microalbuminuria;   Cardiovascular Diseases;   Renal Disease Interventions:   Drug: Fosinopril + Pravastatin;   Drug: Fosinopril + Placebo;   Drug: Pravastatin + Placebo;   Drug: Double Placebo Sponsors:   University Medical Center Groningen;   Dutch Kidney Foundation;   Netherlands Heart Foundation Completed - verified March 2017 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 27, 2017 Category: Research Source Type: clinical trials

Prevention of Renal and Vascular Endstage Disease Intervention Trial
Conditions:   Microalbuminuria;   Cardiovascular Diseases;   Renal Disease Interventions:   Drug: Fosinopril;   Drug: Pravastatin;   Drug: Fosinopril Placebo;   Drug: Pravastatin Placebo Sponsors:   University Medical Center Groningen;   Dutch Kidney Foundation;   Netherlands Heart Foundation Completed - verified March 2017 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 27, 2017 Category: Research Source Type: clinical trials